Welcome to the international HTA database

Showing [16524 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2010	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Non-invasive medical device for the study of syndromes of altered state of consciousness
2010	HAYES, Inc.	UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer
2010	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Portable computed tomography (CT) for the study of diagnostic imaging in specialised areas or setting
2010	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Gefitinib (Iressa) for the first-line treatment of non-small cell lung cancer
2010	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Trabectedin (Yondelis) for second-line recurrent platinum-sensitive ovarian cancer
2010	NIHR Health Technology Assessment programme	Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation
2010	NIHR Health Technology Assessment programme	A randomised controlled equivalence trial to determine the effectiveness and cost utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX)
2010	NIHR Health Technology Assessment programme	Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Impact of clinical and health care services research on advancing knowledge. Study applied to the CAHTAs research calls (third edition)
2010	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Antibiotic therapy in hospital, oral versus intravenous treatment]
2010	NIHR Health Technology Assessment programme	Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial
2010	NIHR Health Technology Assessment programme	Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effect of the organisational development tool Appreciative Inquiry]
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of multidisciplinary ambulant services for patients with chronic diseases]
2010	NIHR Health Technology Assessment programme	BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A
2010	NIHR Health Technology Assessment programme	Systematic review and cost effectiveness evaluation of a 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Drugs for smoking cessation]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Cardiac surgery registry. An international review]
2010	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness of recombinant factor VIIa for off-label indications vs. usual care.
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Biologics for early rheumatoid arhritis]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Review of the efficacy of drug treatment for neuropathic pain]
2010	NIHR Health Technology Assessment programme	Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Treatment of pregnant women with asymptomatic bacterial vaginosis with clindamycin]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Chronic low back pain: the appropriate use of diagnostic imaging procedures]
2010	NIHR Health Technology Assessment programme	A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	Psychological, social and sexual consequences of female genital mutilation/cutting (FGM/C): a systematic review of quantitative studies
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Medtronic-Minimed Continuous Glucose Monitoring System for patients with type 1 diabetes mellitus and gestational diabetes: efficacy and safety]
2010	NIHR Health Technology Assessment programme	Cross-trimester repeated measures testing for Down's syndrome screening: an assessment
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effect of interventions to reduce potentially inappropriate use of medicines in nursing homes: a systematic review of randomised controlled trials]
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effects of school health services for children and young people's health and growing up conditions]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Trabectedin (Yondelis) in the treatment of soft tissue sarcomas]
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Heroin maintenance for persons with chronic heroin dependence]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Laronidase (Aldurazyme) for the treatment of mucopolysaccharidosis I]
2010	NIHR Health Technology Assessment programme	NESTAC: North of England Study of Tonsillectomy and Adeno-tonsillectomy in children
2010	NIHR Health Technology Assessment programme	Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Treatment of patients with acute stroke in stroke units (with or without early supported discharge)]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Assessment process of research projects submitted to the 2009 calling of the Fundacio La Marato de TV3. Rare diseases]
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of interventions outside the health services for increased physical activity among adults]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Impact of clinical and health services research calls on informing decision-making and capacity building. The viewpoint of the researchers]
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Intravenous thrombolytic treatment after acute stroke and secondary antithrombotic prevention treatment (antiplatelet and anticoagulant treatment) after stroke]
2010	NIHR Health Technology Assessment programme	A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	Factors promoting and hindering the practice of female genital mutilation/cutting (FGM/C)
2010	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[BRATS 13: The use of insulin glargine and insulin detemir to control type 1 diabetes mellitus]
2010	NIHR Health Technology Assessment programme	Multi-centre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women scheduled for wide local excision (COMICE)
2010	Medical Advisory Secretariat (MAS)	Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease
2010	Medical Advisory Secretariat (MAS)	Single photon emission computed tomography for the diagnosis of coronary artery disease
2010	Medical Advisory Secretariat (MAS)	Stress echocardiography for the diagnosis of coronary artery disease
2010	NIHR Health Technology Assessment programme	A multicentred randomised controlled trial of a primary-care based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial
2010	Medical Advisory Secretariat (MAS)	Stress echocardiography with contrast for the diagnosis of coronary artery disease
2010	NIHR Health Technology Assessment programme	Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis
2010	Medical Advisory Secretariat (MAS)	64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease
2010	Medical Advisory Secretariat (MAS)	Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease
2010	NIHR Health Technology Assessment programme	Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives
2010	Medical Advisory Secretariat (MAS)	Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis
2010	NIHR Health Technology Assessment programme	LIFELAX - diet and LIFEstyle versus LAXatives in the management of chronic constipation in older people: randomised controlled trial
2010	Medical Advisory Secretariat (MAS)	Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures
2010	Medical Advisory Secretariat (MAS)	Negative pressure wound therapy: an evidence update
2010	NIHR Health Technology Assessment programme	The effectiveness and cost effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model
2010	NIHR Health Technology Assessment programme	Cetuximab for the first line treatment of metastatic colorectal cancer
2010	Medical Advisory Secretariat (MAS)	Epidermal Growth Factor Receptor Mutation (EGFR) testing for prediction of response to EGFR-targeting Tyrosine Kinase Inhibitor (TKI) drugs in patients with advanced non-small-cell lung cancer : an evidence-based and economic analysis
2010	NIHR Health Technology Assessment programme	Avoiding and identifying errors in health technology assessment models
2010	NIHR Health Technology Assessment programme	Infliximab for the treatment of acute exacerbations of ulcerative colitis
2010	NIHR Health Technology Assessment programme	Aripiprazole for the treatment of schizophrenia in adolescents (aged 15-17 years)
2010	Medical Advisory Secretariat (MAS)	Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis
2010	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Medical device for intravesical microwave hyperthermia in the treatment of superficial bladder cancer
2010	NIHR Health Technology Assessment programme	Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2010	Medical Advisory Secretariat (MAS)	Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010	NIHR Health Technology Assessment programme	Golimumab for the treatment of rheumatoid arthritis after failure of previous disease-modifying antirheumatic drugs: a single technology appraisal
2010	NIHR Health Technology Assessment programme	School-linked sexual health services for young people (SSHYP): a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities
2010	NIHR Health Technology Assessment programme	Pazopanib for the first line treatment of patients with advanced and/or metastatic renal cell carcinoma: a single technology appraisal
2010	NIHR Health Technology Assessment programme	Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost effectiveness and value of information analyses
2010	NIHR Health Technology Assessment programme	Vinflunine for the second line treatment of transitional cell carcinoma of the urothelial tract
2010	NIHR Health Technology Assessment programme	Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma
2010	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010	NIHR Health Technology Assessment programme	Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, costeffectiveness and economic analysis
2010	NIHR Health Technology Assessment programme	Chemoprevention of colorectal cancer: systematic review and economic model
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ranolazine (Ranexa®)
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Atazanavir (Reyataz®) capsules
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sildenafil citrate (Revatio®) solution
2010	Blue Cross Blue Shield Association (BCBS)	Gene expression profiling in women with lymph-node-positive breast cancer to select adjuvant chemotherapy treatment
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tipranavir (Aptivus®) capsules
2010	Blue Cross Blue Shield Association (BCBS)	Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2010	HAYES, Inc.	Alair bronchial thermoplasty system (Asthmatx Inc.) for treatment of asthma
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tipranavir (Aptivus®) oral solution
2010	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Bariatric surgery in diabetic type 2 patients with CMI at or above 30 kg/m2]
2010	Blue Cross Blue Shield Association (BCBS)	Special report: positron emission tomography for the indication of post-treatment surveillance of cancer
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Epoetin theta (Eporatio®)
2010	Blue Cross Blue Shield Association (BCBS)	Low-level laser therapy for carpal tunnel syndrome and chronic neck pain
2010	HAYES, Inc.	Autologous stem cell transplantation followed by nonmyeloablative allogeneic stem cell transplantation for treatment of multiple myeloma
2010	Blue Cross Blue Shield Association (BCBS)	Radiofrequency ablation of nondysplastic or low-grade dysplastic barrett's esophagus
2010	Penn Medicine Center for Evidence-based Practice (CEP)	Postpartum management of hypertensive disorders
2010	HAYES, Inc.	Bayley scales of infant (and toddler) development testing (Pearson Education Inc.) for developmental delays in infants
2010	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Olanzapine depot (ZypAdhera)
2010	The Swedish Council on Health Technology Assessment (SBU)	Antibiotic prophylaxis in surgical interventions
2010	Penn Medicine Center for Evidence-based Practice (CEP)	Calibration of computerized drug interaction alerts
2010	Penn Medicine Center for Evidence-based Practice (CEP)	Albumin use in the healthcare setting
2010	HAYES, Inc.	Brainstem Auditory Evoked Response (BAER) for assessment of brainstem dysfunction in patients with chiari malformations
2010	VA Technology Assessment Program (VATAP)	Gadolinium-containing contrast agents for patients with renal disease
2010	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention of catheter-associated venous thrombosis